You are here

cytokine storm

FDA slams the door in Humanigen’s face, rejects emergency use green light, wants more data

Fierce Biotech

Thu, 09/9/21 - 10:50 am

Emergency Use Authorization

Humanigen announces first patient dosed in phase 3 clinical study of lenzilumab in Covid-19

Pharmaceutical Business Review

Mon, 11/2/20 - 10:22 am

clinical trials

A drug from Shkreli's former company Humanigen shows early promise in COVID-19

Fierce Biotech

Wed, 06/17/20 - 10:37 am

FDA clears emergency use of Roche test for COVID-19 ‘cytokine storm’

Pharmaforum

Thu, 06/4/20 - 10:53 am

I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm

Fierce Biotech

Mon, 06/1/20 - 10:37 am

I-Mab Biopharma

After passing safety hurdle, Orpheris kick-starts COVID-19 cytokine storm efficacy test

Fierce Biotech

Thu, 05/28/20 - 10:47 am

clinical trials

Novartis, Incyte's Jakafi boosts its case in graft-versus-host disease with another phase 3 win

Fierce Pharma

Wed, 04/22/20 - 10:45 pm

clinical trials

graft vs host disease

Incyte, Novartis launch drug study to treat coronavirus complication

Marketwatch

Sat, 04/18/20 - 11:22 pm

clinical trials

Noveome to assess ST266 to treat severe inflammatory response linked with COVID-19

Pharmaceutical Business Review

Tue, 03/31/20 - 11:08 am

Noveome Biotherapeutics